We systematically investigate the mass spectrum,spatial configuration and magnetic moment of the ground and p-wave states[cu][cs]with various color-spin configurations in a multiquark color flux-tube model.Numerical r...We systematically investigate the mass spectrum,spatial configuration and magnetic moment of the ground and p-wave states[cu][cs]with various color-spin configurations in a multiquark color flux-tube model.Numerical results indicate that the state Z_(cs)(4000)^(+)can be described as the compact state[cu][cs]with 1^(3)S1.Its main colorspin configuration is[cu]^(1)^(6c)[cs]^(1)^(6c)and its magnetic moment is 0.73μN.The state Z_(cs)(4220)^(+)can be depicted as the compact state[cu][cs]with 1^(1)P_(1)(or 1^(3)P_(1)).Its main color-spin configuration is[cu]^(0)_(3c)[cs]^(0)_(3c)(or[cu]^(0)_(3c)[cs]^(1)_(3c))and its magnetic moment is 0.12μN(or 0.64μN).The physical state should be the mixture of these two different color-spin configurations and deserves further investigation.In addition,we also predict the properties of the states^(0)_(3c)with other quantum numbers in the model.展开更多
AIM:To evaluate the effectiveness and safety of intravitreal ranibizumab(IVR)for diabetic macular edema(DME)in vitrectomized versus non-vitrectomized eyes.METHODS:The PubMed,EMBASE,Web of Science,Cochrane,EBSCO were c...AIM:To evaluate the effectiveness and safety of intravitreal ranibizumab(IVR)for diabetic macular edema(DME)in vitrectomized versus non-vitrectomized eyes.METHODS:The PubMed,EMBASE,Web of Science,Cochrane,EBSCO were comprehensively searched for studies comparing vitrectomized and non-vitrectomized eyes with DME.Clinical outcomes of best-corrected visual acuity(BCVA),central macular thickness(CMT),the mean number of intravitreal injection and adverse events were extracted and analyzed.RESULTS:Six studies involving 641 eyes were included.Final visual gain significantly improved and CMT significantly reduced in vitrectomized eyes at 6mo and 12mo visits(P<0.05).Although the mean reduction in CMT among non-vitrectomized eyes was significantly greater than in vitrectomized eyes at the 6mo[mean difference(MD)=53.57,95%confidence interval(CI):28.03 to 78.72,P<0.0001]and 12mo(MD=49.65,95%CI:19.58 to 79.72,P=0.01),no significant difference was detected in improvement in BCVA at either 6mo(MD=0.05,95%CI:-0.02 to 0.13,P=0.14)or 12mo(MD=0.03,95%CI:-0.04 to 0.09,P=0.43).Injection number of ranibizumab in non-vitrectomized eyes was significantly less than that in vitrectomized eyes during 6-month period(MD=0.60,95%CI:0.16 to 1.04,P=0.008),while there was no statistically significant difference between the two groups during 12mo of follow-up.CONCLUSION:Evidence from current study suggests that IVR was useful for both vitrectomized group and nonvitrectomized group with DME.Although less reduction in macular thickness is found in vitrectomized group,visual improvement between two groups is similar.展开更多
基金supported by the Chongqing Natural Science Foundation(Grant No.cstc2021jcyj-msxm X0078)the Fundamental Research Funds for the Central Universities(Grant No.SWU118111)。
文摘We systematically investigate the mass spectrum,spatial configuration and magnetic moment of the ground and p-wave states[cu][cs]with various color-spin configurations in a multiquark color flux-tube model.Numerical results indicate that the state Z_(cs)(4000)^(+)can be described as the compact state[cu][cs]with 1^(3)S1.Its main colorspin configuration is[cu]^(1)^(6c)[cs]^(1)^(6c)and its magnetic moment is 0.73μN.The state Z_(cs)(4220)^(+)can be depicted as the compact state[cu][cs]with 1^(1)P_(1)(or 1^(3)P_(1)).Its main color-spin configuration is[cu]^(0)_(3c)[cs]^(0)_(3c)(or[cu]^(0)_(3c)[cs]^(1)_(3c))and its magnetic moment is 0.12μN(or 0.64μN).The physical state should be the mixture of these two different color-spin configurations and deserves further investigation.In addition,we also predict the properties of the states^(0)_(3c)with other quantum numbers in the model.
文摘AIM:To evaluate the effectiveness and safety of intravitreal ranibizumab(IVR)for diabetic macular edema(DME)in vitrectomized versus non-vitrectomized eyes.METHODS:The PubMed,EMBASE,Web of Science,Cochrane,EBSCO were comprehensively searched for studies comparing vitrectomized and non-vitrectomized eyes with DME.Clinical outcomes of best-corrected visual acuity(BCVA),central macular thickness(CMT),the mean number of intravitreal injection and adverse events were extracted and analyzed.RESULTS:Six studies involving 641 eyes were included.Final visual gain significantly improved and CMT significantly reduced in vitrectomized eyes at 6mo and 12mo visits(P<0.05).Although the mean reduction in CMT among non-vitrectomized eyes was significantly greater than in vitrectomized eyes at the 6mo[mean difference(MD)=53.57,95%confidence interval(CI):28.03 to 78.72,P<0.0001]and 12mo(MD=49.65,95%CI:19.58 to 79.72,P=0.01),no significant difference was detected in improvement in BCVA at either 6mo(MD=0.05,95%CI:-0.02 to 0.13,P=0.14)or 12mo(MD=0.03,95%CI:-0.04 to 0.09,P=0.43).Injection number of ranibizumab in non-vitrectomized eyes was significantly less than that in vitrectomized eyes during 6-month period(MD=0.60,95%CI:0.16 to 1.04,P=0.008),while there was no statistically significant difference between the two groups during 12mo of follow-up.CONCLUSION:Evidence from current study suggests that IVR was useful for both vitrectomized group and nonvitrectomized group with DME.Although less reduction in macular thickness is found in vitrectomized group,visual improvement between two groups is similar.
